Cyclophosphamide is not associated with clinically relevant late pulmonary dysfunction in Dutch survivors of childhood cancer - the DCCSS-LATER 2 PULM sub-study

R J van Kalsbeek, E A M Feijen, D Bresters, L C M Kremer, S M F Pluijm, O A Asogwa, E van Dulmen-den Broeder, M M van den Heuvel-Eibrink, G O Janssens, W J Tissing, J J Loonen, S J C M M Neggers, H J H van der Pal, C M Ronckers, J C Teepen, A C H de Vries, M Louwerens, M van der Heiden-van der Loo, S M P J Prevaes, A B Versluys*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'Cyclophosphamide is not associated with clinically relevant late pulmonary dysfunction in Dutch survivors of childhood cancer - the DCCSS-LATER 2 PULM sub-study'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology